Clinical Operations, • 9/19/25 How To Prevent Failure in Rare Disease Trials? Previous Leveraging Patient Advocacy To Scale Rare Disease Trials Next Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Reducing Patient Burden in Rare Disease Trials Opening Keynote: The Future of Rare Disease Trials
Clinical Operations, • 9/19/25 How To Prevent Failure in Rare Disease Trials? Previous Leveraging Patient Advocacy To Scale Rare Disease Trials Next Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Reducing Patient Burden in Rare Disease Trials Opening Keynote: The Future of Rare Disease Trials
